Infection Control Market Overview (2021–2028)

The global infection control market was valued at $32.6 billion in 2020 and is expected to reach $38.6 billion by 2028, growing at a CAGR of 3.0% during the forecast period. Infections—ranging from respiratory and gastrointestinal to skin and hospital-acquired infections (HAIs)—are primarily caused by viruses, bacteria, fungi, or parasites.

To mitigate this risk, a wide array of infection control solutions has emerged, including:

Sterilization equipment & services

Cleaning and disinfection products

Protective barriers

Endoscope reprocessing systems

Market Segmentation By Product & Service Sterilization

Equipment: Heat, low-temp, radiation, others

Services: Ethylene oxide, gamma, e-beam sterilization

Consumables: Indicators, packaging accessories

Cleaning & Disinfection

Disinfectants (wipes, liquids, sprays)

Disinfection equipment

Protective Barriers (Highest contributor)

Medical nonwoven: Gowns, face masks, coveralls

Gloves

Endoscope Reprocessing Products

Protective barriers dominate the market due to heightened public awareness, increasing surgical procedures, and mass adoption of masks and gowns during the COVID-19 pandemic.

By End User Hospitals & Clinics (Major share) Driven by the growing number of surgical procedures, higher risk of HAIs, and aging population.

Pharmaceutical & Medical Device Companies

Others (e.g., diagnostic labs, long-term care centers)

Regional Insights 🔹 North America Strong market presence due to robust healthcare infrastructure and strict regulatory standards.

🔹 Asia-Pacific (Fastest growing region, CAGR: 4.3%) Growth fueled by:

Rise in HAIs across emerging countries

Government initiatives and funding for infection prevention

Rapid healthcare development and population base

Increasing adoption of sterilization and disinfection technologies

Leading manufacturers are expanding their footprint in the Asia-Pacific region to capitalize on untapped opportunities and high demand for medical nonwovens and disinfectants.

Key Market Players 3M Company

Ecolab Inc.

Steris Plc (Cantel Medical Corporation)

Getinge AB

Fortive (Advanced Sterilization Products)

Belimed AG

Matachana Group

Miele Group

MMM Group

Sotera Health LLC

These companies are actively investing in product innovation, expanding sterilization capabilities, and targeting emerging regions for growth.

Conclusion The global infection control market remains vital in maintaining healthcare safety standards, particularly in the post-pandemic era. With increasing concerns around HAIs, rising surgical volume, and continuous innovation in protective and sterilization technologies, the market is set for steady growth. Asia-Pacific represents a significant growth frontier, while North America maintains its dominance through advanced infrastructure and regulatory support.